Nitrogen biobank for cardiovascular research

Current Cardiology Reviews

Volumn 9, Issue 3, 2013, Pages 253-259

  Mercuri, Antonella ^a   Turchi, Stefano ^a   Borghini, Andrea ^a   Chiesa, Maria Rosa ^a   Lazzerini, Guido ^a   Musacchio, Laura ^b   Zirilli, Ottavio ^a   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b AIR LIQUIDE   (France)

Author keywords

Congenital heart malformations; CVD; DNA; Gene expression; mRNA; Nitrogen biobank

Indexed keywords

LIQUID NITROGEN; NITROGEN;

ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; HEART DISEASE; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGNOSIS;

BIOLOGICAL SPECIMEN BANKS; CRYOPRESERVATION; HEART DEFECTS, CONGENITAL; HUMANS; METABOLOMICS; NITROGEN; RESEARCH DESIGN; SPECIMEN HANDLING;

EID: 84882752918     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/1573403X113099990035     Document Type: Article

References (44)

1. Riegman PHJ, Morente MM, Betsou F, de Blasio P, Geary P, Marble Arch Int Working G: Biobanking for better healthcare. Mol Oncol 2008; 2: 213-222.
2. Végvári A, Welinder C, Lindberg H, Fehniger TE, Marko-Varga G. Biobank resources for future patient care: developments, principles and concepts. J Clin Bioinforma 2011; 16;:24.
3. Park A. Biobanks. Time 2009; 12 march online: http://www.time.com/time/specials/packages/article/0,28804,1884779_1884782_1884766,00.html
4. Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics 2005; 6: 639-646.
5. OECD Guidelines on human biobanks and genetic research databases 2009Simili. Online: http://www.oecd.org/dataoecd/41/47/44054609.pdf
6. Gottweis H, Lauss G. Biobank governance in the post-genomic age. Personalized Medicine 2010; 7: 187-195.
7. Wilson PW. Progressing from risk factors to omics. Circ Cardiovasc Genet. 2008; 1: 141-146
8. Sikaroodi M, Galachiantz Y, Baranova A. Tumor markers: the potential of "omics" approach Curr Mol Med 2010; 10: 249-245.
9. Vlaanderen J, Moore LE, Smith MT, et al. Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup Environ Med 2010; 67: 136-143.
10. Casado-Vela J, Cebrián A, Gómez del Pulgar MT, Lacal JC. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics. Clin Transl Oncol 2011; 13: 617-628.
11. Feinberg AP. Epigenetics at the epicenter of modern medicine JAMA 2008; 299: 1345-1350.
12. Christensen BC, Marsit CJ. Epigenomics in environmental health. Front Genet 2011; 2: 84.
13. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005; 14: 1847-1850.
14. Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science 2010; 330: 460-461.
15. Thomas DC. High-volume "-omics" technologies and the future of molecular epidemiology. Epidemiology 2006; 17: 490-491.
16. Vineis P, Khan AE, Vlaanderen J, Vermeulen R. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health 2009; 8: 54.
17. Heron M, Sutton PD, Xu J, Ventura SJ, Strobino DM, Guyer B. Annual summary of vital statistics: 2007. Pediatrics 2010; 125: 4-15
18. Lloyd-Jones D, Adams RJ, Brown TM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010; 121: 948-954.
19. Andreassi MG, Gastaldelli A, Clerico A, Salvadori P, Sicari R, Picano E. Imaging and Laboratory Biomarkers in Cardiovascular Disease. Curr Pharmaceut Design 2009; 15: 1131-1141.
20. Hoffman JI and Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-1900.
21. Deanfield J, Thaulow E, Warnes C, et al. Task Force on the Management of Grown Up Congenital Heart Disease, European Society of Cardiology; ESC Committee for Practice Guidelines. Management of grown up congenital heart disease. Eur Heart J 2003; 24: 1035-1084.
22. Cresci M, Foffa I, Ait-Ali L, et al. Maternal and Paternal Environmental Risk Factors, Metabolizing GSTM1 and GSTT1 Polymorphisms and Congenital Heart Disease. Am J Cardiol 2011; 108: 1625-1631.
23. Pulignani S, Cresci M, Andreassi MG. Genetics of congenital heart defects: is it not all in the DNA? Transl Res 2013; 161: 59-61.
24. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
25. Barsheshet A, Brenyo A, Moss AJ, Goldenberg I. Genetics of sudden cardiac death. Curr Cardiol Rep 2011; 13: 364-376.
26. Rodríguez-Calvo MS, Brion M, Allegue C, Concheiro L, Carracedo A. Molecular genetics of sudden cardiac death. Forensic Sci Int 2008; 182: 1-12.
27. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 2006; 692-705.
28. Winn DM, Gunter EW. Biologic specimen banks: a resource for molecular epidemiologic studies. In: Molecular Epidemiology: Principles and Practices, Shulte PA and Perera FP, eds. Academic Press, Orlando, FL, 1993; 217-233.
29. OECI-EEIG From the biobank to the research repository: ethical and legal recommendations. 2010 Online: www.progettorol.it/doc/OECI_BIOBANKS_Oct.2010.pdf
30. Elliott P, Peakman TC; UK Biobank. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 2008; 37: 234-244
31. Holland NT, Smith MT, Eskenazi B, Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003; 543: 217-234.
32. Tuck MK, Chan DW, Chia Godwin AK, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009; 8: 113-117.
33. Schrohl AS, Würtz S, Kohn E, et al. Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics 2008; 7: 2061-2066.
34. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999; 6: 89-95.
35. Lewis MR, Callas PW, Jenny NS, Tracy RP. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 2001; 86: 1495-1450.
36. Kisand K, Kerna I, Kumm J, Jonsson H, Tamm A. Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples. Clin Chem Lab Med 2011; 49: 229-235.
37. Rouy D, Ernens I, Jeanty C, Wagner DR. Plasma storage at-80 °C does not protect matrix metalloproteinase-9 from degradation. Anal Biochem 2005; 338: 294-298.
38. Steinberg KK, Sanderlin KC, Ou CY, Hannon WH, McQuillan GM, Sampson EJ. DNA banking in epidemiologic studies, Epidemiol Rev 1997; 19: 156-162.
39. Fagan M, Ball P. Design and implementation of a large-scale liquid nitrogen archive. Int J Epidemiol 2008; 37: 62-64.
40. Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 2008; 37: 234-244.
41. Grout BWW and Morris, GJ. The Effects of Low Temperatures on Biological Systems. Edward Arnold, London, UK 1987.
42. Farrant J. General observations on cell preservation. In: Low Temperature Preservation in Medicine and Biology, (Ashwood-Smith, M. and Farrant, J., eds.), Pitman Medical, Tonbridge Wells, UK, 1980; 1-18.
43. Baker M. Biorepositories: Building better biobanks. Nature 2012; 486: 141-146.
44. Clement O. Biological sample storage and management, Lab Manager: 26-29, 2009.